Document is current
Any future updates will be listed below
-
Authors
Kuutti, Katariina https://orcid.org/0000-0001-9642-2598
Laakso, Sini M.
Viitala, Matias
Atula, Sari
Soilu-Hänninen, Merja
-
Funding
Funding for this research was provided by:
The Finnish MS Foundation
Finnish Governmental Research Funds of Southwestern Finland
Finnish Governmental Research Funds of Helsinki University Hospital
University of Turku
- License Information
-
More Information
Article History
Received: 9 February 2025
Revised: 17 April 2025
Accepted: 22 April 2025
First Online: 2 May 2025
Declarations
:
: KK has nothing to disclose. SL has served as an adviser or speaker for Alexion, Argenx, Novartis, Merck, Jansen, Lundbeck, Sanofi, Teva, and UCB Pharma, and received support for congress participation from Novartis, Merck, and UCB Pharma. MV has nothing to disclose. SA has served as an adviser or speaker for Biogen, Novartis, Roche, and Sanofi. MS-H has served as an adviser or speaker for Biogen, Novartis, Roche, Sanofi, and Teva, and received support for congress participation from Biogen, Merck, and Novartis.
